A current approach to heart failure in Duchenne muscular dystrophy
Abstract
Duchenne muscular dystrophy (DMD) is a genetic, progressive neuromuscular condition that is marked by the long-term muscle deterioration with significant implications of pulmonary and cardiac dysfunction. As such, end-stage heart failure (HF) in DMD is increasingly becoming the main cause of death in this population. The early detection of cardiomyopathy is often challenging, due to a long subclinical phase of ventricular dysfunction and difficulties in assessment of cardiovascular symptomatology in these patients who usually loose ambulation during the early adolescence. However, an early diagnosis of cardiovascular disease in patients with DMD is decisive since it allows a timely initiation of cardioprotective therapies that can mitigate HF symptoms and delay detrimental heart muscle remodelling. Echocardiography and ECG are standardly used for screening and detection of cardiovascular abnormalities in these patients, although these tools are not always adequate to detect an early, clinically asymptomatic phases of disease progression. In this regard, cardiovascular magnetic resonance (CMR) with late gadolinium enhancement is emerging as a promising method for the detection of early cardiac involvement in patients with DMD. The early detection of cardiac dysfunction allows the therapeutic institution of various classes of drugs such as corticosteroids, beta-blockers, ACE inhibitors, antimineralocorticoid diuretics and novel pharmacological and surgical solutions in the multimodal and multidisciplinary care for this group of patients. This review will focus on these challenges and available options for HF in patients with DMD.Keywords
This publication has 54 references indexed in Scilit:
- Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patientsThe Journal of Heart and Lung Transplantation, 2013
- Re-examination of the Electrocardiogram in Boys With Duchenne Muscular Dystrophy and Correlation With Its Dilated CardiomyopathyThe American Journal of Cardiology, 2009
- Management of Cardiac Involvement in NeuroMuscular Diseases: ReviewThe Open Cardiovascular Medicine Journal, 2008
- Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from the Pediatric Cardiomyopathy RegistryAmerican Heart Journal, 2008
- Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-upAmerican Heart Journal, 2007
- Left Ventricular Function and Response to Enalapril in Patients With Duchenne Muscular Dystrophy During the Second Decade of LifeThe American Journal of Cardiology, 2006
- The muscular dystrophiesThe Lancet, 2002
- Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophyNeuromuscular Disorders, 1993
- The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophyInternational Journal of Cardiology, 1990
- Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging.Circulation, 1984